Eris Lifesciences to meet Franklin Templeton on May 29

0 min read     Updated on 26 May 2026, 06:03 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Eris Lifesciences Limited announced a virtual investor meeting with Franklin Templeton scheduled for May 29, 2026. The session, led by Mr. Krishnakumar Vaidyanathan at 10:30 AM IST, will rely on publicly available documents and will not involve unpublished price sensitive information.

powered bylight_fuzz_icon
41236322

*this image is generated using AI for illustrative purposes only.

Eris Lifesciences Limited has announced that its management will participate in an investor conference with Franklin Templeton. The meeting is scheduled to take place virtually on Friday, May 29, 2026.

The interaction will be led by Mr. Krishnakumar Vaidyanathan, a management representative from the company. The session is set to begin at 10:30 AM IST and will be conducted in a one-on-one format.

Meeting Details

The following table outlines the specifics of the scheduled interaction:

Day and Date Fund Name Management Representatives Mode of Meeting Meeting Details
Friday, May 29, 2026 Franklin Templeton Mr. Krishnakumar Vaidyanathan Virtual 10:30 AM IST, 1X1

The company has clarified that the schedule provided is indicative and subject to change due to unforeseen developments. During the meeting, the management will refer to publicly available documents for discussions.

Eris Lifesciences Limited emphasized that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Eris Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.58%+1.89%-0.88%-15.79%-11.68%+95.14%

What key strategic priorities is Eris Lifesciences likely to highlight during the Franklin Templeton conference?

How might the insights shared by Mr. Vaidyanathan influence investor sentiment toward Eris Lifesciences?

Could this meeting signal potential collaborations or increased interest from Franklin Templeton in Eris Lifesciences?

Eris Lifesciences appoints Vineet Varma as Independent Director

1 min read     Updated on 26 May 2026, 02:35 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Eris Lifesciences Limited announced that shareholders have approved the appointment of Mr. Vineet Varma as an Independent Director. The resolution passed with 99.92% of votes in favour through a remote e-voting process held from April 24 to May 23, 2026.

powered bylight_fuzz_icon
41283211

*this image is generated using AI for illustrative purposes only.

Eris Lifesciences Limited has secured shareholder approval to appoint Mr. Vineet Varma as an Independent Director. The resolution was passed via a remote e-voting process conducted under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The appointment received overwhelming support, with 99.92% of the votes cast in favour of the motion.

The remote e-voting period commenced on April 24, 2026, and concluded on May 23, 2026. Mr. Ravi Kapoor, Practicing Company Secretary, served as the Scrutinizer for the process and submitted his report on May 25, 2026. The resolution required a special majority, which was achieved as the votes in favour significantly exceeded the votes against.

A total of 299 members participated in the remote e-voting process, representing 122,595,692 shares. The detailed voting breakdown reveals strong backing across different shareholder categories, including promoters and public institutions.

Voting Results Summary

Category Votes In Favour Votes Against Total Votes Polled % In Favour
Promoter and Promoter Group 74,708,644 0 74,708,644 100.00
Public - Institutions 32,752,100 96,568 32,848,668 99.71
Public - Non Institutions 15,037,743 457 15,038,200 99.997
Total 122,498,487 97,025 122,595,512 99.92

The postal ballot notice was dispatched to shareholders on April 23, 2026. The company engaged MUFG Intime India Private Limited as the service provider to facilitate the electronic voting process. The results have been uploaded to the company’s website and the platform of the registrar and share transfer agent.

Historical Stock Returns for Eris Lifesciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.58%+1.89%-0.88%-15.79%-11.68%+95.14%

What specific expertise will Mr. Varma bring to the board, and how might this influence Eris Lifesciences' strategic direction?

How will the addition of a new independent director impact the company's governance framework and committee compositions?

Could this appointment signal upcoming shifts in Eris Lifesciences' management structure or expansion into new therapeutic areas?

More News on Eris Lifesciences

1 Year Returns:-11.68%